HBM Alpha

HBM Alpha Therapeutics is a biotechnology company. The company is currently developing antibody therapies for rare genetic diseases, congenital adrenal hyperplasia (CAH), and polycystic ovary syndrome (PCOS). Its treatments can also be applied to other endocrine disorders associated with the dysfunction and regulation of the hypothalamic-pituitary-adrenal (HPA) axis.